Johnson & Johnson

Change company Symbol lookup

Select an option...

JNJ Johnson & Johnson

HSTRF Hollister Biosciences Inc

T AT&T Inc

SPHD Invesco S&P 500® High Dividend Low Volatility ETF

MSFT Microsoft Corp

PEY Invesco High Yield Equity Dividend Achievers™ ETF

BAC Bank of America Corp

ARI Apollo Commercial Real Estate Finance Inc

ISNPY Intesa Sanpaolo SpA

BRKR Bruker Corp

Go

Shawn Langlois That's Gene Goldman, chief investment officer at Cetera Financial Group, talking to Bloomberg News (https://www.bloomberg.com/news/articles/2021-01-23/hedge-funds-beef-up-tech-holdings-before-apple-amazon-earnings)about a...(MarketWatch)

Shawn Langlois That's Gene Goldman, chief investment officer at Cetera Financial Group, talking to Bloomberg News (https://www.bloomberg.com/news/articles/2021-01-23/hedge-funds-beef-up-tech-holdings-before-apple-amazon-earnings)about a...(MarketWatch)

In the latest trading session, Johnson & Johnson (JNJ) closed at $162.38, marking a -0.25% move from the previous day.(Zacks)

(END) Dow Jones Newswires January 20, 2021 09:16 ET (14:16 GMT) (MarketWatch)

By The New York Post Dr. Anthony Fauci on Sunday that Johnson & Johnson and AstraZeneca could send studies of their COVID-19 vaccines to the feds for approval within "weeks." (MarketWatch)

By The New York Post Dr. Anthony Fauci on Sunday that Johnson & Johnson and AstraZeneca could send studies of their COVID-19 vaccines to the feds for approval within "weeks." (MarketWatch)

Shares of Johnson & Johnson (JNJ) gained 1.7% in premarket trading on Thursday, the day after a study (https://www.nejm.org/doi/full/10.1056/NEJMoa2034201%7CNEW) published in the New England Journal of Medicine showed that its COVID-19...(MarketWatch)

Federal officials have been told that Johnson & Johnson's (JNJ) vaccine production has fallen as much as two months behind the original production schedule and won't catch up until the end of April, The New York Times reported...(MarketWatch)

By Joy Wiltermuth and Sunny Oh Rising Treasury yields also in focus Stock indexes booked modest losses Monday, backing off from Friday's records, as investors remained optimistic about the prospects for the incoming Biden...(MarketWatch)

By Lina Saigol The U.K government wants to have 13 million of those people most at risk vaccinated by mid February The COVID-19 vaccine candidate being developed by Johnson & Johnson (JNJ) subsidiary Janssen Pharmaceutica could be...(MarketWatch)

By Lina Saigol The U.K government wants to have 13 million of those people most at risk vaccinated by mid February The COVID-19 vaccine candidate being developed by Johnson & Johnson (JNJ) subsidiary Janssen Pharmaceutica could be...(MarketWatch)

Coca-Cola Co. US:KO -1% 3M Co. US:MMM -1% American Express Co. US:AXP -3% Verizon Communications Inc...(MarketWatch)

By Lina Saigol Valneva's is the fifth COVID-19 vaccine candidate in the U.K., but scientists have warned that it could take at least a year to inoculate the entire population (MarketWatch)

Tomi Kilgore U.S. death count passes 304,000 and as hospitalizations near 113,000 Nearly 3,000 people died from COVID-19 in the past day and hospitalizations rose to just below 113,000, to mark a 10th-straight daily record, just days...(MarketWatch)

Tomi Kilgore U.S. death count passes 304,000 and as hospitalizations near 113,000 Nearly 3,000 people died from COVID-19 in the past day and hospitalizations rose to just below 113,000, to mark a 10th-straight daily record, just days...(MarketWatch)

Pierre Briançon 'No, I never considered it was risky, and no, of course, I'm not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of volunteering for a vaccine trial in London (MarketWatch)

Pierre Briançon 'No, I never considered it was risky, and no, of course, I'm not getting paid. I just received my second shot a few days ago,' writes Pierre Briançon of volunteering for a vaccine trial in London (MarketWatch)

Pierre Briançon "No, I never considered it was risky, and no, of course, I'm not getting paid. I just received my second shot a few days ago. " The first question that came to my friends' minds was whether I'd really thought about the...(MarketWatch)

By Lina Saigol The European Union has now negotiated six supply deals with vaccine makers to secure COVID-19 shots The European Union has struck a deal with U.S. biotech Moderna (MRNA) for the supply of up to 160 million doses of its...(MarketWatch)

By Lina Saigol The European Union has struck a deal with U.S. biotech Moderna (MRNA) for the supply of up to 160 million doses of its experimental COVID-19 vaccine, the head of the European Commission said on Tuesday. (MarketWatch)